Goodman Corey S
CIK 0001278411
Director10% Owner
Filings
17
Latest Feb 4, 2026
Issuers covered
6
Showing
17 of 17
Page 1
Track record
2 of 23 open-market trades scored (9% price coverage) - 21 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +8.0% | +8.0% | +30.4% | -14.4% |
| 90 days | 2 | 50% | +0.5% | +0.5% | +11.9% | -11.0% |
| 180 days | 1 | 0% | -39.9% | -39.9% | -39.9% | -39.9% |
| 365 days | 1 | 0% | -78.1% | -78.1% | -78.1% | -78.1% |
Issuers
Companies where Goodman Corey S has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CMPI | Checkmate Pharmaceuticals, Inc. | 7 | May 17, 2022 |
| ALXO | Alx Oncology Holdings Inc | 6 | Feb 4, 2026 |
| ARTV | Artiva Biotherapeutics, Inc. | 1 | Jul 22, 2024 |
| ELEV | Elevation Oncology, Inc. | 1 | May 27, 2022 |
| RYZB | Rayzebio, Inc. | 1 | Sep 21, 2023 |
| VTYX | Ventyx Biosciences, Inc. | 1 | Jun 10, 2022 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|